The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
DRUG

Betamethasone Dipropionate Nasal Cream 0.0644%

Betamethasone Dipropionate Nasal Cream 0.0644% is applied topically to the inflamed tissue of the sinus using a pre-filled syringe and applicator under the guidance of an endoscope. Up to 5g on each side of the sinus (10g in total).

DEVICE

Pre-filled syringe and applicator device

Cream is pre-filled to a syringe and applicator device to facilitate the topical application direct to the sinus under endoscopic guidance.

Trial Locations (4)

2153

RECRUITING

Oticara Investigational Site, Sydney

4029

RECRUITING

Oticara Investigational Site, Brisbane

5042

RECRUITING

Oticara Investigational Site, Adelaide

6163

RECRUITING

Oticara Investigational Site, Perth

All Listed Sponsors
lead

Oticara Australia PTY LTD

INDUSTRY